Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Morgan Stanley reiterated its baseline call that the Federal Reserve will maintain current interest rates through the end of the year, but cautioned that a drop in the unemployment rate below 4.0% or sustained higher inflation readings could force policymakers to consider additional rate hikes. Analyst Michael Gapen cited recent data, lower oil pri…
Deutsche Bank moved Tate & Lyle from Buy to Hold after the stock advanced nearer to Ingredion's proposed takeover price. The bank left its 595p target unchanged and pointed to a reduced risk-reward profile, while noting deal timing and potential antitrust clearances across multiple jurisdictions as material uncertainties.
Marlene Amstad, president of Swiss market regulator FINMA and chair of an international supervisory technology forum, said regulators and banks must accelerate adoption of new technology to close gaps that AI is exposing in financial systems. FINMA has helped create a forum within the International Organization of Securities Commissions to promote …
Cabaletta (CABA) pulled back after positive EULAR data that highlighted rese-cel safety and durable responses in autoimmune indications. The reaction looks overdone: fundamentals and upcoming regulatory/catalyst timelines support a tactical long into registrational progress. This trade idea lays out entry, stop, target, rationale and risks over a 1…
Amazon is down after the market started treating AI spending like a binary bet. That view ignores AWS profitability, advertising strength, and a potential new Trainium chip revenue stream. At $227.52, the risk/reward is attractive. This trade plan targets $275 with a $210 stop, sized for a long-term horizon (180 trading days).
Vivani Medical, a clinical-stage biopharmaceutical company, announced the appointment of August Moretti to its board of directors, replacing retiring board member Dr. Dean Baker. This leadership change coincides with the company's ongoing development of its lead semaglutide implant, NPM-139, and its proprietary NanoPortal technology for chronic dis…
Acadia Pharmaceuticals' stock rose after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending DAYBU (trofinetide) for treating neurobehavioral symptoms of Rett syndrome in patients aged five and older. The recommendation, based principally on results from the Phase 3 LAVENDER trial, w…
Titan Mining's shares climbed 34% after its Empire State Mines unit received conditional selection notices from the U.S. Army to develop graphite purification facilities on two defense installations. The Kilbourne Graphite Purification Plant is planned for Pine Bluff Arsenal and Anniston Army Depot under Enhanced Use Lease authority, with construct…
Anger over recent Ukrainian drone strikes and frustration with what they view as an unsuccessful U.S. mediation have led Russian nationalist figures to press President Vladimir Putin to abandon diplomacy and increase military measures. Calls from hardliners include full mobilisation, attacks on European drone factories, destruction of Kyiv’s govern…
Shares of Omeros Corporation (NASDAQ:OMER) declined about 14% on Friday morning following a negative recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) on Yartemlea (narsoplimab). The CHMP advised against approving the drug for treatment of adults and children aged two and older with haematopoi…
Three major Chinese brokerage units - Yongan Futures, Orient Futures and Guotai Junan Futures - are preparing applications to join the London Metal Exchange (LME), according to sources. The move would increase China's representation among clearing members on the LME and reflects these brokers' efforts to capture more revenue from global metals deri…
U.S. solar developers have hurried to secure federal tax credits before a July 4 deadline, creating a pipeline of projects large enough to almost double current solar capacity. The accelerated phaseout of long-standing subsidies under the 2025 tax law risks lifting contract prices for wind and solar by 40% to 50% and in some Texas deals by as much …
Tiptree trades at a materially low multiple of cash flow with modest leverage and a pending asset sale that should either return capital or materially increase per‑share cash. We propose a long trade at $17.32 with a $26.00 target over 180 trading days and a $15.00 stop — a risk/reward that favors patient buyers if management moves to distribute pr…
UBS has trimmed its combined semiconductor and hardware allocation within its AI-focused investment strategy to roughly 61% from about 76%, selling into a rally led by Micron that pushed the SOXX index up 4% in one session and 10% in June. The bank reallocated capital into defensive parts of the AI ecosystem, and reiterated that medium-term AI dema…
Kyivstar Group Ltd., a Nasdaq-listed Ukrainian digital operator, signed a Memorandum of Understanding with the National Securities and Stock Market Commission of Ukraine to explore ways for local investors to access its existing Nasdaq-listed shares through established brokerage channels. This initiative aims to connect Ukrainian investors with hom…
Expro Group (XPRO) is a niche oilfield-services operator with a improving margin profile, low leverage, and recurring contract backlog that support upside from current levels. With a market cap around $1.58B, attractive EV/EBITDA near 4.9x and strong free cash flow, XPRO looks like a value-oriented swing trade with clearly defined entry, stop and t…
Axsome Therapeutics has begun dosing the first patient in its FOCUS-3 Phase 3 clinical trial evaluating solriamfetol as a treatment for adolescents with ADHD. This trial will assess the efficacy and safety of two doses of solriamfetol in approximately 468 patients aged 12 to under 18 years, with the goal of addressing a significant unmet medical ne…
Avalo Therapeutics, a clinical stage biotech company focused on IL-1β pathway therapeutics for immune-mediated inflammatory diseases, announced it will be added to the Russell 2000 and Russell 3000 Indexes as of June 26, 2026. This inclusion reflects the company’s growth and increased visibility among institutional investors. Avalo recently reporte…
Balchem Corporation, a global specialty ingredient manufacturer serving health and nutrition markets, announced it will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives including the CEO, CFO, and Senior Director of Investor Relations will represent the company at the event.
Jade Biosciences, a clinical-stage biotech company focusing on autoimmune therapies, announced the addition of Mark Eisner, M.D., M.P.H., an experienced biopharmaceutical executive, to its Board of Directors. Dr. Eisner brings over 25 years of leadership in clinical development and immunology, expected to support Jade's advancement of its antibody-…
Baker Hughes will announce its second quarter 2026 earnings on July 26, 2026, followed by a webcast discussion on July 27. The company continues to leverage its energy technology expertise across global markets.
Fortrea announces the appointment of Jason Knoblauch as Chief Financial Officer, succeeding Jill McConnell. Knoblauch brings extensive CRO and financial leadership experience. The company reiterates its 2026 financial guidance with expected revenue between $2.55 billion and $2.65 billion and adjusted EBITDA between $190 million and $220 million. Th…
Kyivstar Group Ltd., a Nasdaq-listed Ukrainian digital operator, has signed a Memorandum of Cooperation with Ukraine's National Securities and Stock Market Commission to advance capital markets and expand investment opportunities for Ukrainian citizens by enabling access to Kyivstar's shares through local brokerage channels. This initiative aims to…
Aurora Mobile Limited partners with Hebei Yuanda Information Technology to integrate its JPush intelligent push notification system into the Caiyuan Gungun App. This technology upgrade delivers millisecond-level message delivery with high concurrency support across multiple device ecosystems, improving timely, personalized financial information dis…
Tilray Medical, a division of Tilray Brands, expands its medical cannabis access for UK veterans by introducing the 'Lyphe for Veterans' program at the Aldershot Armed Forces Weekend. The program removes financial and access barriers for veterans seeking medically regulated cannabis treatments, reflecting Tilray's commitment to responsible healthca…
